## 

||Page|
|---|---|
|Report ofthe Trustees and Strategic Report|1<br>— 11|
|Report ofthe Independent Auditors|12— 15|
|Statementof Financial Activities|16|
|Balance Sheet|17|
|Cash Flow Statement|18|
|Notes to the Cash Flow Statement|19|
|Notes to the Financial Statements|20—27|





## 

## 

|Trustees||
|---|---|
|Mr C Barratt|Chair ofTrustees & Chair of Finance and Audit Committee|
|Ms C Dodwell|Deputy Chair and Chair of the Capital Developments Committee|
|Mr C Bridge|Chair of the Integrated Governance Committee|
|Mr RG Hammond|Chair of the Workforce and Remuneration Committee|
|Dr C S Ince||
|Mr L Marlow|Chair of the Finance and Audit Committee|
|Ms S Watson||
|Mr N Smillie|Appointed August2019|
|Mr A Appleton|Appointed April 2020|
|Mr MRPA Manning|Appointed December2020|
|Mr Suriwala|Resigned December2020|
|Key Management Personnel:||
|Ms C Nolan||
|Chief Executive Officer||



## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

|<br><br>fthegovernancefr<br>n them:|a|mework. In total t|here are five Boa|rd committees an|d these are the Di|rectorswho serv|
|---|---|---|---|---|---|---|
||I|Director|Integrated|Finance and|Capital|Workforce|
|Committees||Appointments|Governance|Audit|Development|and<br>Remuneration|
|Mr C Barratt||Chair|x|x||x|
|Mr C Bridge|||Chair|X|||
|Ms C Dodwell|||||Chair||
|Mr R G Hammond||X|||X|Chair|
|DrCSlnce||X|x||||
|Mr L Marlow||||Chair|X|x|
|Ms S Watson|||x||||
|Mr N Smillie|||x||||
|MrA Appleton|||||X||



## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 




23rd September 2021 



## 

## 

|||2020|2019|
|---|---|---|---|
|||Unrestricted|Unrestricted|
|||funds|funds|
|||£|£|
||Notes|||
|INCOME||||
|Donations and legacies<br>Investmentincome|3<br>4|-<br>-|1,150<br>325|
|Incoming resources from charitable activities<br>Medical services provided<br>Other income|5|9826,734<br>64387|13,953,947<br>11,294|
|Total income||9,891,121|13,966,716|
|EXPENDITURE||||
|Charitable activities||||
|Medical services provided|6|10,797,843|13930,820|
|Total expenditure||10,797,843|13930,820|
|NET (EXPENDITURE)IINCOME||(906,722)|35,896|
|Total funds broughtforward||12,996,862|12,960,966|
|TOTAL FUNDS CARRIED FORWARD||12,090,140|12,996,862|



## 



## 

||||2020|2019|
|---|---|---|---|---|
||||Unrestricted|Unrestricted|
||||funds|funds|
||Notes||£|£|
|FIXED ASSETS|||||
|Intangible assets<br>Tangible assets<br>Total Fixed Assets|13<br>14||26,076<br>12,423204<br>12,449,280|35568<br>12,808,865<br>12,844,433|
|CURRENTASSETS<br>Stocks<br>Debtors: amounts falling due within one year<br>Cashatbank|15<br>16||353,188<br>1,236,656<br>522,172|324,108<br>1,264,410<br>748,041|
||||2,112,016|2,336,559|
|CREDITORS|||||
|Amounts falling due within one year|17||(1,080,956)|(1,393930)|
|NET CURRENT ASSETS|||1,031,060|942,629|
|TOTAL ASSETS LESS CURRENT LIABILITIES|||13,480,340|13,787,062|
|CREDITORS|||||
|Amounts falling due aftermore than one year|18||(1,390,200)|(790,200)|
|NET ASSETS||-|12,090,140|12,996,862|
|FUNOS<br>Unrestricted funds|20||12,090,140|12,996,862|
|TOTAL FUNDS|||12,090,140|12,996862|





## 

## 

|||2020|2019|
|---|---|---|---|
||Notes|£|£|
|Cash flow from operating activities||||
|Netcash (used in)/provided by operating activities|I|(597241)|699830|
|Cash flows from investing activities<br>Purchaseofintangibleassets<br>Purchase ofproperty, plant and equipment<br>Interest received||(7936)<br>(220,692)<br>-|(23,082)<br>(320,774)<br>325|
|Net cash used in investing activities||(228,628)|(343,531)|
|Cash flows from financing activities||||
|Loan drawn down in year||600,000|-|
|Net cash from investing activities||600,000||
|Change in cash and cash equivalents in the reporting period||(225,869)|356,299|
|Cash and cash equivalents at the beginning of the reporting||748,041|391,742|
|period||||
|Cash and cash equivalents at the end of the reporting|2|522,172|748,041|
|period||||





## 

## 

||RECONCILIATION OF NET INCOME TO NET CASH INFLOW|FROM OPERATI|NG ACTIVIT|
|---|---|---|---|
|||2020|2019|
|||£|£|
||Net (expenditure)Iincomefor reporting period (as perthe|(906,722)|35896|
||statement offinancial activities)<br>Amortisation ofintangible assets<br>Depreciation charges<br>Interest received|17,428<br>530,537<br>-|21,929<br>491,682<br>(325)|
||(Increase)/decrease in stocks<br>Decrease/(increase) in debtors<br>(Decrease)/increase in creditors|(29,080)<br>27,369<br>(236773)|11,845<br>(65817)<br>204,620|
||Net cash provided by operating activities|(597,241)|699,830|
|2.|ANALYSIS OF CASH AND CASH EQUIVALENTS|||
|||2020|2019|
|||£|£|
||Cash|522,172|748,041|



## 

|NALYSIS OF CHANGES IN NET DEBT||||
|---|---|---|---|
||At||At31|
||1 January|Cash flow|December|
||2020||2020|
||£|£|£|
|Net cash:||||
|Cash at bank|748,041|(225,869)|522,172|
|Bank Loan due in greater than one year||(600,000)|(600,000)|
||748,041|(825,869)|(77,828)|





## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

|3.|DONATIONS AND LEGACIES|||
|---|---|---|---|
|||2020|2019|
|||£|£|
||Legacies and Donations|-|1,150|
|4.|INVESTMENT INCOME|||
|||2020|2019|
|||£|£|
||Bank interest|-|325|





## 

## 

||||2020|2019|
|---|---|---|---|---|
||||£|£|
|Medical|services|provided|9,826,734|13,953,947|



## 

||Direct Medical|Supportcosts|Governance|Total|Total|
|---|---|---|---|---|---|
||costs|(see note 12)|Costs (see|2020|2019|
||(see note 7)<br>£|£|£<br>note 8)|£|£|
|Medical services|7,645,390|3,131,573|20,880|10,797,843|13,930,820|
|Provided||||||



## 

|DIRECT COSTS OF CHARITABLE ACTIVITIES|||
|---|---|---|
||2020|2019|
||£|£|
|Staffcosts|2,871,466|2,613,604|
|Direct medical costs|4,051,503|7,163,392|
|Insurance|333,167|267,707|
|Patient services|111,108|139,113|
|Medical Equipment Maintenance and Repair|278,146<br>7,645,390|308,280<br>10,492,096|



## 

|8.|GOVERNANCE COSTS|||
|---|---|---|---|
|||2020|2019|
|||£|£|
||Auditors’ remuneration|20,880|16,680|
|9.|NET (EXPENOITLJRE)IINCOME|||
||Net (experiditure)/iricome is stated afterchargirtg/(crediting):|||
|||2020|2019|
|||£|£|
||Auditor’s remuneration|20,880|16,680|
||Amortisation of intangibleassets<br>Depreciation of owned assets|17,428<br>530,537|21929<br>491,682|



## 



## 

## 

|STAFF COSTS AND THE COST OF KEY MANAGEME|NT PERSONNEL||
|---|---|---|
||2020|2019|
||£|£|
|Salaries and wages:<br>-<br>Nursing and otherclinical staff<br>-<br>Housekeeping, catering and maintenance<br>•<br>Management and administration|2,509,237<br>509,638<br>1,163,997<br>4,182,872|2,553798<br>515923<br>1,154994<br>4,224,715|
|Wage and salaries<br>Social security costs<br>Pension costs|3,781420<br>305739<br>95,713|3839,485<br>297,153<br>88,077|
||4,182,872|4,224,715|



|ithin the foll|owing range|
|---|---|
|2020|2019|
|Number|Number|
|1|1|



|Average number employed (including temporary staf|f):||
|---|---|---|
||2020|2019|
|Nursing and other clinical<br>Management, clerical and domestic|112<br>95<br>207|110<br>95<br>205|



## 

|Support costs incurred in the year in relation t|o charitable activities were as follo|ws:|
|---|---|---|
||2020|2019|
||£|£|
|Management<br>Finance|1,813,105<br>70,490|2,156,060<br>53,935|
|Information Technology<br>Property|305,652<br>942,327<br>3,131,573|278,499<br>933,550<br>3,422,044|





## 

## 

## 

|INTANGIBLE FIXED ASSETS||
|---|---|
||Total|
||Software|
||£|
|COST||
|Ati January2020|110,567|
|Additions|7936|
|At31 December2020|118503|
|DEPRECIATION||
|At 1 January 2020<br>Charge for year|74999<br>17,428|
|At 31 December2020|92,427|
|NET BOOK VALUE||
|At 31 December2020|26076|
|At31 December2019|35568|



## 

|TANGIBLE FIXED ASSETS|||||
|---|---|---|---|---|
||||Medical||
||||Equipment,||
||Freehold<br>land|Freehold<br>property|Fixtures,<br>Fittings,|T<br>I<br>o a|
||||Computer||
||||Equipment||
||£|£|£|£|
|COST|||||
|At 1 January 2020<br>Additions|3,366,366<br>-|8,796202<br>10116|3,163,026<br>134,760|15,325594<br>144876|
|At 31 December 2020|3366366|8806,318|3,297,786|15470,470|
|DEPRECIATION|||||
|At 1 January 2020<br>Chargeforyear|-<br>-|1,010,572<br>178,440|1,506,157<br>352,097|2516729<br>530,537|
|At 31 December 2020|-|1189,012|1,858,254|3047266|
|NET BOOK VALUE|||||
|At 31 December 2020<br>At 31 December 2019|3.366.366<br>3.366366|Z&3L<br>LZ|J22|J2Q<br>12.808.865|



## 

|STOCKS|||||
|---|---|---|---|---|
||||2020|2019|
||||£|£|
|Consumable <br>Pharmacy|medical|supplies|326,910<br>26278<br>353,188|304,059<br>20,049<br>324,108|





## 

## 

|16.|DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR|||
|---|---|---|---|
|||2020|2019|
|||£|£|
||Trade debtors|872562|1012375|
||Prepayments and accrued income|364094<br>1236656|252035<br>1264410|
|17.|CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR|||
|||2020|2019|
|||£|£|
||Trade creditors|498,915|846,280|
||Social security and othertaxes<br>Accruals and deferred income|95,807<br>486,234|94,844<br>452,806|
|||1080,956|1.393930|



## 

|||2020|2019|
|---|---|---|---|
|||£|£|
|CBILS <br>Lease|Loan (Note 19)<br> deposits|600,000<br>790,200<br>1,390,200|-<br>790,200<br>790200|



## 

## 

|OVEMENT IN|FUNDS|||||||
|---|---|---|---|---|---|---|---|
||At<br>January<br>2020|Incoming<br>Resources|Resources<br>Expended|Funds<br>transferred|Gains<br>and<br>Losses||At<br>December<br>2020|
||£|£|£|£|£||£|
|Unrestricted||||||||
|funds<br>Generalfund<br>Total Funds|12,996,862<br>12,996862|9,891,121<br>9,891121|(10,797843)<br>(10.797,843)|-||-<br>-|12,090,140<br>12,090,140|





## 

## 

|ANALYSIS OF RESERVES|||
|---|---|---|
||2020|2019|
||£|£|
|Total reserves|12,090,140|12,996,862|
|Less: Land and buildings|(10,406,598)|(11,151,996)|
|Add: Lease deposits relating to land and buildings<br>Freely available reserves|790200<br>2,473742|790200<br>2,635,066|
|FINANCIAL INSTRUMENTS|||
||2020|2019|
||£|£|
|Financial assets measured atamortised cost|1,428476|1,760,416|
|Financial liabilities measured at amortised cost|1,889,115|1,636,480|



## 

## 

